Examining the Global Genetic Prevalence of TK2d

NeuroFrontiers by ReachMD

Apr 30, 202600:14:01Health

Host: Brian P. McDonough, MD, FAAFP Guest: Austin Larson, MD Emerging research on thymidine kinase 2 deficiency (TK2d) provides new insights into its global genetic prevalence and variability across genetic ancestries. B...

Related Episodes

Continue listening to more episodes from NeuroFrontiers.

Can We Delay Alzheimer's Symptoms Before They Begin? Inside the PrevenTRON Trial

Aug 31, 2026 - 00:08:31

No Label: Geoff Kerchner Dr. Geoff Kerchner, Vice President and Global Head of Neurodegeneration at Roche...

Subcutaneous Lecanemab for Early Alzheimer Disease: Evidence, Safety, and Patient Selection

Aug 20, 2026 - 00:11:37

No Label: Michael Irizarry, MD, MPH Dr. Michael Irizarry, Senior Vice-President, Clinical Research, Eisai...

Next-Generation CNS Drug Delivery: Brainshuttle Technology and Clinical Implications in Alzheimer Disease

Jul 17, 2026 - 00:15:25

No Label: Luka Kulic, MD In this episode, Luka Kulic, MD, Vice President and Global Head of Early Clinica...

Advancing MOGAD Care

Jun 24, 2026 - 00:10:04

No Label: Michael Levy, MD, PhD No Label: Peter V. Sguigna, MD What do the latest METEOROID trial results...

Multidisciplinary Coordination in TK2d Diagnosis and Management

Jun 24, 2026 - 00:11:15

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Zarazuela Zolkipli-Cunningham, MBChB, MRCP Guest: Oscar H...

Navigating Stem Cell Therapy Conversations in MS

Jun 8, 2026 - 00:04:45

Guest: Jaime Imitola, MD As stem cell therapies continue to generate significant interest among patients...

Cognitive Screening in MS: Practical Strategies and Modern Approaches

May 28, 2026 - 00:03:30

Guest: Elizabeth S. Gromisch, PhD Cognitive changes are a common but complex aspect of multiple sclerosis...

Identifying the Respiratory Manifestations of TK2d: The Pulmonologist’s Role

May 14, 2026 - 00:14:45

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Bethany Lussier, MD Patients often present with respirato...